Tudor Investment Corp
DMRA

Tudor Investment Corp’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Tudor Investment Corp’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,164
Closed -$274K – 2583
2021
Q2 		$274K Sell
2,164
-154
-7% -$21K 0.01% 1381
2021
Q1 		$352K Sell
2,318
-259
-10% -$70.4K 0.01% 1251
2020
Q4 		$806K Buy
+2,577
New +$958K 0.02% 765

Other funds holding DMRA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tudor Investment Corp's DMRA Position: Q3 2021 in Review

Tudor Investment Corp sold out of Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q3 2021, closing a stake of 2,164 shares — an estimated $274K sold.

Tudor Investment Corp first reported a position in DMRA in Q4 2020 and held it in 3 quarters. The position peaked at $806K in Q4 2020. 25 funds tracked by Wall St. Rank hold DMRA as of Q3 2021.

  • Tudor Investment Corp reported no remaining Damora Therapeutics, Inc. Ordinary Shares position as of Q3 2021 after selling out during the quarter.
  • Tudor Investment Corp sold 2,164 Damora Therapeutics, Inc. Ordinary Shares shares in Q3 2021, an estimated $274K.
  • Tudor Investment Corp first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q4 2020 and held it in 3 quarters.
  • Tudor Investment Corp's Damora Therapeutics, Inc. Ordinary Shares position peaked at $806K in Q4 2020.
  • 25 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q3 2021.

Based on Tudor Investment Corp's 13F filing for Q3 2021, filed 15 Nov 2021.